White blood cell count | 3.8–10.5 x109/L | 27.39 | 7.15 |
Red blood cell count | 4.2–5.8 x1012/L | 2.22 | 3.5 |
Haemoglobin | 130.0–170.0 g/L | 50 | 110 |
Haematocrit | 39.0%–50.0% | 15.1 | 33.6 |
Mean cell volume | 80.0–100.0 fl | 90.5 | 96 |
Red cell distribution width | 10.3%–14.5% | 14.5 | 16 |
Platelet Count | 150–400 x109/L | 127 | 281 |
Prothrombin time | 10.6–13.6 s | 12.2 | 11.3 |
International normalised ratio | 0.88–1.16 | 1.02 | 0.98 |
Activated partial thromboplastin time (aPTT) | 27.5–35.5 s | 63.6 | 32.6 |
D-dimer | <229 ng/mL | 672 | |
aPTT 100% | 27.5–35.5 s | 74 | |
aPTT 50/50 2-hour Incubation | 27.5–35.5 s | 71.9 | |
aPTT 50/50 | 27.5–35.5 s | 44.1 | |
Diluted thrombin time | 16.0–25.0 s | 24.7 | |
Factor V level | 50%–150% | 114 | |
Factor IX level | Report | Normal activity | |
Factor II level | 80%–135% | 66 | |
Factor VII level | 50%–165% | 77 | |
Factor X level | 70%–170% | 77 | |
Factor XI level | 70%–145% | 30 | |
Factor XII level | 45%–150% | 36 | |
Factor XIII level | 51%–163% | 37 | |
Factor VIII assay | 60–125 | <1 | 96 |
Inhibitor assay (Factor VIII) | 0.0–0.5 Bethesda unit | 176 | 0 |